Relmada Therapeutics (RLMD) Return on Capital Employed Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 68,255.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 2,665.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 31,429.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2,503.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -105.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,400.00
10 Relmada Therapeutics 595.35 Mn 595.35 Mn - 21,129.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21,129.00
Dec 31, 2025 8,414.00
Sep 30, 2025 -28,591.00
Jun 30, 2025 -23,216.00
Mar 31, 2025 -12,571.00
Dec 31, 2024 -9,348.00
Sep 30, 2024 -5,791.00
Jun 30, 2024 -2,250.00
Mar 31, 2024 -1,269.00
Dec 31, 2023 -1,141.00
Sep 30, 2023 -2,109.00
Jun 30, 2023 -3,187.00
Mar 31, 2023 -4,495.00
Dec 31, 2022 -1,387.00
Sep 30, 2022 4,937.00
Jun 30, 2022 1,354.00
Mar 31, 2022 683.00
Dec 31, 2021 -3,281.00
Sep 30, 2021 -9,809.00
Jun 30, 2021 -6,482.00
Mar 31, 2021 -5,165.00
Dec 31, 2020 -2,501.00
Jun 30, 2020 30,618.00
Mar 31, 2020 133,349.00
Dec 31, 2019 172,639.00
Mar 31, 2019 317,902.00
Dec 31, 2018 -132,887.00
Sep 30, 2018 102,577.00
Mar 31, 2018 -432,027.00
Dec 31, 2017 -26,915.00
Sep 30, 2017 -67,970.00
Jun 30, 2017 -14,698.00
Mar 31, 2017 -7,234.00
Dec 31, 2016 -1,853.00
Sep 30, 2016 -7,801.00
Jun 30, 2016 -3,026.00
Mar 31, 2016 36,328.00
Dec 31, 2015 83,976.00
Sep 30, 2015 -19,427.00